comparemela.com
Home
Live Updates
FDA and EMA Accept Regulatory Submissions for Vorasidenib fo
FDA and EMA Accept Regulatory Submissions for Vorasidenib fo
FDA and EMA Accept Regulatory Submissions for Vorasidenib for IDH-Mutant Diffuse Glioma
Vorasidenib has been granted regulatory submission acceptance by the FDA and EMA for IDH-mutant diffuse glioma.
Related Keywords
,
Claude Bertrand ,
Susan Pandya ,
European Commission ,
Cancer Metabolism Global Development Oncology Immuno ,
Meeting Of The Society For Neuro ,
European Medicines Agency ,
Research Development ,
Marketing Authorization Application ,
New England Journal ,
Cancer Metabolism Global Development Oncology ,
Prescription Drug User Fee Act ,
Vorasidenib ,
Idh Mutant Diffuse Glioma ,
D ,